ExploreWatchlistsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Total liabilities

Fuji Pharma Co.,Ltd. (4554)

Market cap
¥61.9B
P/E ratio
27.2x
Develops and manufactures specialized injectable medications for hospitals and medical distributors, focusing on hormone treatments and medical imaging contrast agents.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Sep 30, 202546,496+4.63%
Sep 30, 202444,437+0.64%
Sep 30, 202344,155+11.13%
Sep 30, 202239,732+25.91%
Sep 30, 202131,557+43.43%
Sep 30, 202022,001+2.94%
Sep 30, 201921,373+20.30%
Sep 30, 201817,767+4.83%
Sep 30, 201716,949-10.42%
Sep 30, 201618,921+10.13%
Sep 30, 201517,180-16.12%
Sep 30, 201420,482

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat